Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.2921
-0.0079 (-2.63%)
Jan 26, 2026, 3:43 PM EST
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $473.62 million as of January 26, 2026. Its market cap has increased by 30.92% in one year.
Market Cap
473.62M
Enterprise Value
559.51M
Revenue
937.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.29
Market Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 473.62M, an increase of 4,503.09%. That is a compound annual growth rate of 17.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 473.62M | 32.15% |
| Dec 31, 2025 | 358.39M | -1.53% |
| Dec 31, 2024 | 363.95M | -55.71% |
| Dec 29, 2023 | 821.84M | -1.00% |
| Dec 30, 2022 | 830.10M | 25.14% |
| Dec 31, 2021 | 663.34M | -47.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 321.76M |
| Silence Therapeutics | 267.82M |
| Vaxart | 160.74M |
| HST Global | 131.71M |
| BioStem Technologies | 120.12M |
| Nuo Therapeutics | 75.80M |
| Arch Biopartners | 60.99M |
| Vicapsys Life Sciences | 48.56M |